Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design | Journal of Medicinal Chemistry
![Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK - The Lancet Respiratory Medicine Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/fe3b4b9d-0dde-4a7f-b2e3-823357e1f023/gr1.jpg)
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK - The Lancet Respiratory Medicine
![Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://www.thelancet.com/cms/asset/94597f5b-8f00-4c9a-9442-ec00415b36da/gr1.jpg)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
![NC State University August 2021 Commencement Program by NC State Enrollment Management and Services - Issuu NC State University August 2021 Commencement Program by NC State Enrollment Management and Services - Issuu](https://image.isu.pub/210827233849-699cecad93e1894a0440751dbd0a1cab/jpg/page_1.jpg)
NC State University August 2021 Commencement Program by NC State Enrollment Management and Services - Issuu
![Atomistic Simulations and In Silico Mutational Profiling of Protein Stability and Binding in the SARS-CoV-2 Spike Protein Complexes with Nanobodies: Molecular Determinants of Mutational Escape Mechanisms | ACS Omega Atomistic Simulations and In Silico Mutational Profiling of Protein Stability and Binding in the SARS-CoV-2 Spike Protein Complexes with Nanobodies: Molecular Determinants of Mutational Escape Mechanisms | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.1c03558/asset/images/medium/ao1c03558_0011.gif)
Atomistic Simulations and In Silico Mutational Profiling of Protein Stability and Binding in the SARS-CoV-2 Spike Protein Complexes with Nanobodies: Molecular Determinants of Mutational Escape Mechanisms | ACS Omega
![Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates | Science Advances Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf1591/asset/6128813c-5c05-49bb-8a20-ba2299854486/assets/graphic/abf1591-f1.jpeg)
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates | Science Advances
![Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design | Journal of Medicinal Chemistry Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm201376w/asset/images/medium/jm-2011-01376w_0003.gif)
Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design | Journal of Medicinal Chemistry
![Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke | ACS Medicinal Chemistry Letters Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/acsmedchemlett.1c00599/asset/images/medium/ml1c00599_0002.gif)
Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke | ACS Medicinal Chemistry Letters
![Open Letter to Vice President Mike Pence RE: US COVID-19 Response | by Dr. Maxine Dexter and Dr. Smitha Chadaga | Medical Professionals for a better COVID-19 Response | Medium Open Letter to Vice President Mike Pence RE: US COVID-19 Response | by Dr. Maxine Dexter and Dr. Smitha Chadaga | Medical Professionals for a better COVID-19 Response | Medium](https://miro.medium.com/max/1400/1*l7SOC5-W3nGgCUxbUDfVuQ.png)
Open Letter to Vice President Mike Pence RE: US COVID-19 Response | by Dr. Maxine Dexter and Dr. Smitha Chadaga | Medical Professionals for a better COVID-19 Response | Medium
![Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet](https://www.thelancet.com/cms/asset/f3be98d8-d68c-4273-a286-fc9e5079f0d6/gr1.jpg)